Autoradiographic characterization of [18 F]PSMA-1007 binding in rat brain.

Thomsen, Majken B; Landau, Anne M; Bender, Dirk; Cumming, Paul (2023). Autoradiographic characterization of [18 F]PSMA-1007 binding in rat brain. Synapse, 77(6), e22280. Wiley-Liss 10.1002/syn.22280

Preview

Text Synapse_-_2023_-_Thomsen_-_Autoradiographic_characterization_of_18F_PSMA_1007_binding_in_rat_brain.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (518kB) | Preview

Carboxypeptidase II (CBPII) in brain metabolizes the neuroactive substance N-acetyl-L-aspartyl-L-glutamate (NAGG) to yield the elements of glutamate and N-acetyl-aspartate (NAA). In peripheral organs, CBPII is known as prostrate specific membrane antigen (PSMA), which presents an important target for nuclear medicine imaging in prostate cancer. Available PSMA ligands for PET imaging do not cross the blood-brain barrier, and there is scant knowledge of the neurobiology of CBPII, despite its implication in the regulation of glutamatergic neurotransmission. In this study we used the clinical PET tracer [18 F]-PSMA-1007 ([18 F]PSMA) for an autoradiographic characterization of CGPII in rat brain. Ligand binding and displacement curves indicated a single site in brain, with KD of about 0.5 nM, and Bmax ranging from 9 nM in cortex to 19 nM in white matter (corpus callosum and fimbria) and 24 nM in hypothalamus. The binding properties of [18 F]PSMA in vitro should enable its use for autoradiographic investigations of CBPII expression in animal models of human neuropsychiatric conditions.

Interest & Impact

Downloads

65 since deposited on 04 Jul 2023
54 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item